Recommendations supporting respiratory syncytial virus vaccines marketed by Pfizer (NYSE:PFE) and GSK (NYSE:GSK) made last month by an advisory panel to the CDC are under review from a top advisor to HHS Secretary Robert F. Kennedy Jr.
William “Reyn” Archer III was